What strategies can be utilized to accurately diagnose Hodgkin lymphoma in areas that lack adequate pathology?

FAQ published on January 11, 2016
Download Transcript Download Audio
Bruce D. Cheson, MD
Professor of Medicine
Director of Hematology Research
Georgetown University Hospital
Lombardi Comprehensive Cancer Center
Washington, DC
What strategies can be utilized to accurately diagnose Hodgkin lymphoma in areas that lack adequate pathology?
Welcoming to Managing Hodgkin Lymphoma. My name is Bruce Cheson and I am deputy chief of hematology/oncology and head of hematology at Georgetown University Hospital and the Lombardi Comprehensive Cancer Center. I am frequently asked, “What strategies can be utilized to accurately diagnose Hodgkin lymphoma in areas that lack adequate pathology?” Well unfortunately, pathology is rather important in making the diagnosis, but there are several components to this. There is morphology, looking at it under the microscope, and that is critical to making the diagnosis. There are other diagnostic tools such as immunohistochemistry which confirm the diagnosis but are not essential in making that diagnosis; if you look under the microscope, you see the Reed-Sternberg cells, you may see the sclerosis of nodular sclerosing Hodgkin lymphoma, it is not that difficult but it is important to make an accurate diagnosis so that you can treat the patients appropriately. Thank you for viewing this activity. For additional resources, please view the other educational activities on ManagingHodgkinLymphoma.com.
Last modified: January 6, 2016
Related Items by Author
What alternatives may be used to accurately stage Hodgkin lymphoma if PET-CT is not available?
Bruce D. Cheson, MD
FAQ published on March 3, 2016
Is CD30 an accurate diagnostic marker in lymphomas other than Hodgkin lymphoma?
Bruce D. Cheson, MD
FAQ published on February 3, 2016